WCP2026 Satellite Meeting: Inflammation, Fibrosis and Metabolism - Centre of Research Excellence in Pulmonary Fibrosis

Join global pharmacology and technological leaders at the WCP2026 Satellite Meeting: Inflammation, Fibrosis and Metabolism on Saturday, 11 July 2026 at Bio21 Institute, University of Melbourne.

This exciting satellite meeting precedes the main World Congress of Pharmacology 2026, bringing together world-renowned researchers and experts to explore cellular and extracellular mechanics in treating inflammation, fibrosis, and metabolic disease.

Keynote speakers include Em Prof Clive Page (King’s College London) and Dr Danilo Tagle (NIH) and other international thought leaders.

Open call for 3-minute thesis, 15-minute talks, and poster presentations.

Limited spaces available, register today via Eventbrite

WCP2026 Satellite Meeting: Inflammation, Fibrosis and Metabolism WCP2026-Satellite-Meeting-flyer-1-page79.pdf (opens in new tab)

Pulmonary Fibrosis Institute

The Centre of Research Excellence in Pulmonary Fibrosis has established the Pulmonary Fibrosis Institute, a not-for-profit company registered in Australia. The Pulmonary Fibrosis Institute exists to support ongoing research into pulmonary fibrosis and ensure the longevity of research infrastructure developed through our collaborative efforts.